FGF2 then binds to fibroblast growth factor receptor 4 (FGFR4) on HCC cells, activating the ERK1 pathway to promote HCC cell proliferation and forming a positive signaling loop between tumor cells and endothelial cells (106). Here, FGFR4 is linked to hepatocellular carcinoma.